Mutants of H-ras that interfere with RAS effector function in Saccharomyces cerevisiae
- PMID: 2684634
- PMCID: PMC401381
- DOI: 10.1002/j.1460-2075.1989.tb08454.x
Mutants of H-ras that interfere with RAS effector function in Saccharomyces cerevisiae
Abstract
We report a class of interfering mutants of the human H-ras gene capable of inhibiting phenotypes arising from the expression of the activated RAS2 gene, RAS2val19, in the yeast Saccharomyces cerevisiae. All these mutants encode unprocessed H-ras proteins that remain in the cytoplasm. One of the mutants, H-rasarg186, was examined in detail. H-rasarg186 protein is a competitive inhibitor of RAS2val19 protein. It does not interfere with processing and membrane localization of RAS2val19, nor does it appear to compete with RAS protein for its proposed regulator, the CDC25 protein. By several criteria the RAS2val19 adenylate cyclase interaction is unaffected by H-rasarg186. We infer from our results that H-rasarg186 protein interferes with an alternative function of RAS2val19.
Similar articles
-
In yeast, RAS proteins are controlling elements of adenylate cyclase.Cell. 1985 Jan;40(1):27-36. doi: 10.1016/0092-8674(85)90305-8. Cell. 1985. PMID: 2981630
-
The S. cerevisiae CDC25 gene product regulates the RAS/adenylate cyclase pathway.Cell. 1987 Mar 13;48(5):789-99. doi: 10.1016/0092-8674(87)90076-6. Cell. 1987. PMID: 3545497
-
Different kinetic properties of the two mutants, RAS2Ile152 and RAS2Val19, that suppress the CDC25 requirement in RAS/adenylate cyclase pathway in Saccharomyces cerevisiae.J Biol Chem. 1990 Jan 25;265(3):1563-8. J Biol Chem. 1990. PMID: 2104846
-
Exploring the function of RAS oncogenes by studying the yeast Saccharomyces cerevisiae.Princess Takamatsu Symp. 1986;17:253-60. Princess Takamatsu Symp. 1986. PMID: 3332013 Review.
-
Upstream regulation of Saccharomyces cerevisiae adenylate cyclase.Biochem Soc Trans. 1989 Dec;17(6):976-8. doi: 10.1042/bst0170976. Biochem Soc Trans. 1989. PMID: 2560745 Review. No abstract available.
Cited by
-
ras isoprenylation is required for ras-induced but not for NGF-induced neuronal differentiation of PC12 cells.J Cell Biol. 1991 Nov;115(3):795-808. doi: 10.1083/jcb.115.3.795. J Cell Biol. 1991. PMID: 1918164 Free PMC article.
-
Synthetic peptides of the Rab effector domain inhibit vesicular transport through the secretory pathway.EMBO J. 1990 Aug;9(8):2375-83. doi: 10.1002/j.1460-2075.1990.tb07412.x. EMBO J. 1990. PMID: 2114975 Free PMC article.
-
Specific isoprenoid modification is required for function of normal, but not oncogenic, Ras protein.Mol Cell Biol. 1992 Jun;12(6):2606-15. doi: 10.1128/mcb.12.6.2606-2615.1992. Mol Cell Biol. 1992. PMID: 1375323 Free PMC article.
-
A synthetic peptide of the rab3a effector domain stimulates amylase release from permeabilized pancreatic acini.Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1656-60. doi: 10.1073/pnas.89.5.1656. Proc Natl Acad Sci U S A. 1992. PMID: 1371881 Free PMC article.
-
Two dominant inhibitory mutants of p21ras interfere with insulin-induced gene expression.Mol Cell Biol. 1991 Dec;11(12):5963-7. doi: 10.1128/mcb.11.12.5963-5967.1991. Mol Cell Biol. 1991. PMID: 1658621 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous